ESPR logo

Esperion Therapeutics (ESPR) Total Assets

Annual Total Assets

$205.80 M
-$42.14 M-17.00%

31 December 2023

ESPR Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$314.11 M
-$38.20 M-10.84%

30 September 2024

ESPR Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ESPR Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.0%+41.9%
3 y3 years-41.7%+39.5%
5 y5 years+43.5%+23.1%

ESPR Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-46.1%at low-17.7%+52.6%
5 y5 years-46.1%+43.5%-17.7%+74.9%
alltimeall time-46.1%+9341.5%-17.7%+4195.6%

Esperion Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$314.11 M(-10.8%)
June 2024
-
$352.32 M(-5.6%)
Mar 2024
-
$373.06 M(+81.3%)
Dec 2023
$205.80 M(-17.0%)
$205.80 M(-7.0%)
Sept 2023
-
$221.31 M(-5.7%)
June 2023
-
$234.63 M(-6.8%)
Mar 2023
-
$251.82 M(+1.6%)
Dec 2022
$247.94 M(-35.0%)
$247.94 M(-20.7%)
Sept 2022
-
$312.83 M(+2.9%)
June 2022
-
$303.98 M(-11.3%)
Mar 2022
-
$342.85 M(-10.2%)
Dec 2021
$381.59 M(+8.0%)
$381.59 M(+69.4%)
Sept 2021
-
$225.26 M(-19.7%)
June 2021
-
$280.46 M(+0.7%)
Mar 2021
-
$278.61 M(-21.1%)
Dec 2020
$353.26 M(+64.7%)
$353.26 M(+40.8%)
Sept 2020
-
$250.97 M(-24.0%)
June 2020
-
$330.35 M(+83.9%)
Mar 2020
-
$179.64 M(-16.2%)
Dec 2019
$214.45 M(+49.5%)
$214.45 M(-16.0%)
Sept 2019
-
$255.27 M(-17.3%)
June 2019
-
$308.81 M(+30.6%)
Mar 2019
-
$236.48 M(+64.9%)
Dec 2018
$143.45 M
$143.45 M(-17.6%)
Sept 2018
-
$174.03 M(-17.5%)
June 2018
-
$210.88 M(-13.6%)
DateAnnualQuarterly
Mar 2018
-
$244.19 M(-12.1%)
Dec 2017
$277.83 M(+13.3%)
$277.83 M(-11.3%)
Sept 2017
-
$313.09 M(+69.0%)
June 2017
-
$185.24 M(-13.7%)
Mar 2017
-
$214.61 M(-12.5%)
Dec 2016
$245.21 M(-17.0%)
$245.21 M(-7.0%)
Sept 2016
-
$263.79 M(-4.9%)
June 2016
-
$277.47 M(-3.0%)
Mar 2016
-
$286.04 M(-3.2%)
Dec 2015
$295.57 M(+106.3%)
$295.57 M(-3.5%)
Sept 2015
-
$306.39 M(-3.0%)
June 2015
-
$315.96 M(-2.8%)
Mar 2015
-
$325.22 M(+127.0%)
Dec 2014
$143.28 M(+83.0%)
$143.28 M(+136.7%)
Sept 2014
-
$60.53 M(-12.6%)
June 2014
-
$69.29 M(-1.3%)
Mar 2014
-
$70.22 M(-10.3%)
Dec 2013
$78.29 M(+970.7%)
$78.29 M(-9.6%)
Sept 2013
-
$86.58 M(+343.2%)
June 2013
-
$19.53 M(-12.3%)
Mar 2013
-
$22.27 M(+204.5%)
Dec 2012
$7.31 M(+235.5%)
$7.31 M
Dec 2011
$2.18 M(-95.8%)
-
Dec 2002
$51.41 M(-34.4%)
-
Dec 2001
$78.34 M(+0.6%)
-
Dec 2000
$77.88 M(+873.6%)
-
Dec 1999
$8.00 M
-

FAQ

  • What is Esperion Therapeutics annual total assets?
  • What is the all time high annual total assets for Esperion Therapeutics?
  • What is Esperion Therapeutics annual total assets year-on-year change?
  • What is Esperion Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Esperion Therapeutics?
  • What is Esperion Therapeutics quarterly total assets year-on-year change?

What is Esperion Therapeutics annual total assets?

The current annual total assets of ESPR is $205.80 M

What is the all time high annual total assets for Esperion Therapeutics?

Esperion Therapeutics all-time high annual total assets is $381.59 M

What is Esperion Therapeutics annual total assets year-on-year change?

Over the past year, ESPR annual total assets has changed by -$42.14 M (-17.00%)

What is Esperion Therapeutics quarterly total assets?

The current quarterly total assets of ESPR is $314.11 M

What is the all time high quarterly total assets for Esperion Therapeutics?

Esperion Therapeutics all-time high quarterly total assets is $381.59 M

What is Esperion Therapeutics quarterly total assets year-on-year change?

Over the past year, ESPR quarterly total assets has changed by +$92.81 M (+41.94%)